nephro care ipo

Nephro Care IPO

  • Status: Closed
  • RHP:
  • ₹ 136,000 / 1600 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    05 Jul 2024

  • Listing Price

    ₹ 171.00

  • Listing Change

    90.00%

  • Last Traded Price

    ₹ 255.00

IPO Details

  • Open Date

    28 Jun 2024

  • Close Date

    02 Jul 2024

  • IPO Price Range

    ₹ 85 to ₹ 90

  • IPO Size

    ₹ 41.26 Cr

  • Listing Exchange

    NSE SME

  • Listing Date

    05 Jul 2024

With just a few clicks, Invest in IPO's!

+91

By proceeding, you agree to all T&C*

hero_form

Nephro Care IPO Subscription Status

Last Updated: 03 July 2024 12:32 PM by 5Paisa

Last Updated: 2nd July, 2024 by 5paisa

Nephro Care India IPO is all set to open from 28th June to 2nd July 2024. The company operates as a one-stop treatment center based in Kolkata. The IPO includes a fresh issue of 4,584,000 shares worth ₹41.26 cr. The share allotment date is 3rd July 2024, and the IPO will be listed on 5th July 2024 on the stock exchanges. The price band is ₹85 to ₹90 and the lot size is 1600 shares.

Corporate Capital Ventures Private Limited is the book-running lead manager for this IPO, while Bigshare Services Private Limited is the registrar. 

Objectives of Nephro Care IPO

Nephro Care India Limited plans to utilize the raised capital from the IPO to:

●    To fund the setup of Multi Speciality Hospital – Vivacity Multi Specialty Hospital (unit of Nephro Care) at Kolkata, West Bengal.
●    General corporate purposes.

Nephro Care IPO Size

Types Size (₹Cr)
Total IPO size 41.26
Offer for sale -
Fresh issue 41.26

Nephro Care IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 ₹144,000
Retail (Max) 1 1600 ₹144,000
HNI (Min) 2 3,200 ₹288,000

Nephro Care IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)
QIB 245.14 8,25,600 20,23,87,200 1,821.48
NII (HNI) 1,787.19 6,19,200 1,10,66,25,600 9,959.63
Retail 634.12 14,44,800 91,61,77,600 8,245.60
Total 715.78 31,15,200 2,22,98,01,600 20,068.21

Nephro Care IPO Anchor Allocation

Anchor Bid Date 27 June, 2024
Total no. of shares offered 1,238,400
Portion Size for Anchor Investors 11.15 Cr. 
Lock in Period for 50% shares (30 days) 2 August, 2024
Lock in Period for rest of shares (90 days) 1 October, 2024

Nephro Care India operates as a one-stop treatment center based in Kolkata. The company provides clinical and lifestyle solutions and services and renal insufficiency treatment.

Its range of treatments and services includes the following:

●    In-house Dialysis Unit 
●    Outpatient Services in areas of Nephrology, Diabetology, Cardiology, Ophthalmology and Neurology 
●    NABL accredited in-house Pathology 
●    Inhouse Pharmacy 
●    Advance diagnostic facilities 
●    Renal Nutrition department 
●    Home Care 8. Mukti (Lifestyle Support Program) 
●    Home Dialysis 

The company serves 900 Chronic Kidney Disease Patients monthly and has 5+ permanent doctors and 10 visiting consultants in its Salt Lake clinic in Chandannagar, West Bengal.


Peer Comparison

●    No listed peers.

For More Information
Webstory on Nephro Care India IPO

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY22 FY21
Revenue from operations 17.09 3.42 1.82
EBITDA 3.64 0.12 0.15
PAT 1.94 -0.0098 0.08
Particulars (in Rs. Crores) FY23 FY22 FY21
Total Assets 8.31 4.62 1.12
Share Capital 0.50 0.50 0.01
Total Borrowings 5.87 4.13 1.11
Particulars (in Rs. Crores) FY23 FY22 FY21
Net cash generated from / (used in) operating activities 4.30 0.61 0.22
Net cash from / (used in) investing activities -2.51 -2.81 -0.06
Net cash flow from / (used in) financing activities -0.08 2.32 0.28
Net increase (decrease) in cash and cash equivalents 1.70 0.13 0.44


Strengths

1.    The company is bridging the gap between day care and tertiary care services and addresses the unmet needs of the patient.
2.    It has a Social Media Powered Community Engagement Model.
3.    The company has a strong focus on developing and commercializing new and improved methodologies and formats of service delivery.
4.    The ‘Hub-and-spoke’ model with a focus on quality patient care supported by modern infrastructure is a big plus. 
5.    It has a strong focus on Clinical Research and Innovations.
6.    A good track record of operational and financial performance.
7.    Experienced promoters and management team.
 

Risks

1.    Its business is mainly dependent on the revenues from the flagship Salt Lake clinic.
2.    It is also highly dependent on healthcare professionals.
3.    Pricing regulations and related government reforms can impact the business. 
4.    It operates in a highly competitive industry. 
5.    It has reported negative cash flow in the past. 
6.    The company has incurred losses in the past.
 

Will You Apply for Nephro Care IPO?

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
footer_form

FAQs

Nephro Care IPO opens from 28th June to 2nd July 2024.
 

The size of Nephro Care IPO is ₹41.26 cr. 
 

To apply for Nephro Care IPO, follow the steps given below:

●    Login to your 5paisa account and select the issue in the current IPO section    
●    Enter the number of lots and the price at which you wish to apply for Nephro Care IPO.    
●    Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.    

You will receive a mandate notification to block funds in your UPI app.
 

The price band of Nephro Care IPO is fixed at ₹85 to ₹90 per share. 
 

The minimum lot size of Nephro Care IPO is 1600 shares and the investment required is ₹1,36,000.
 

The share allotment date of Nephro Care IPO is 3rd July 2024.
 

The Nephro Care IPO will be listed on 5th July 2024.
 

Corporate Capital Ventures Private Limited is the book-running lead manager for Nephro Care IPO.
 

Nephro Care plans to utilize the raised capital from the IPO to:

●    To fund the setup of Multi Speciality Hospital – Vivacity Multi Specialty Hospital (unit of Nephro Care) at Kolkata, West Bengal.
●    General corporate purposes.